Stocks
Athira Pharma, Inc.ATHA
NASDAQHealthcareBiotechnology$6.75-6.12%
Focused on therapies for neurodegenerative diseases, the company develops small‑molecule drugs aimed at conditions such as Alzheimer’s and Parkinson’s disease dementia. Its pipeline is built around compounds designed to stimulate neurotrophic signaling pathways to support neuron survival and functio...
Market Cap: $26.6M52W Range: $2.20 – $8.36
Congressional Interest in Athira Pharma, Inc. (ATHA)
1 member of Congress has disclosed 3 trades in Athira Pharma, Inc. (ATHA), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
2
Sells
1
Who in Congress Is Trading ATHA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |